United States · FDA National Drug Code directory

QUADRACEL

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 49281-564_b943f360-e126-45d4-af57-3fcb4c68d1b2
Product NDC: 49281-564
Form: INJECTION, SUSPENSION
Composition / generic term: diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine
Labeler: Sanofi Vaccines US Inc.
Marketing category: BLA
Marketing start / end (source format): 20150324
Source listing expiry: 20271231

Source-listed ingredients

CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) — 15 [Lf]/.5mL
CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) — 5 [Lf]/.5mL
BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED) — 20 ug/.5mL
BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) — 20 ug/.5mL
BORDETELLA PERTUSSIS PERTACTIN ANTIGEN — 3 ug/.5mL
BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN — 5 ug/.5mL
POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED) — 29 [D'ag'U]/.5mL
POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED) — 7 [D'ag'U]/.5mL
POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED) — 26 [D'ag'U]/.5mL

These values do not establish equivalence or a dose recommendation.

Packages

10 VIAL, SINGLE-USE in 1 PACKAGE (49281-564-10) / .5 mL in 1 VIAL, SINGLE-USE (49281-564-58) · 49281-564-10
10 SYRINGE in 1 PACKAGE (49281-564-15) / .5 mL in 1 SYRINGE (49281-564-88) · 49281-564-15

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →